AstraZeneca PLC (AZN) stock
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
AstraZeneca's enterprise value was $536.85B on Oct 19, 2026, against $539.40B a year earlier. Over the last 5 years it ranged from $141.10B to $673.77B, with a median of $469.54B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $536.85B | -10.4% |
| 2025 | Dec 31, 2025 | $598.99B | +37.8% |
| 2024 | Dec 31, 2024 | $434.83B | -2.0% |
| 2023 | Dec 29, 2023 | $443.51B | +8.0% |
| 2022 | Dec 30, 2022 | $410.83B | +180.2% |
| 2017 | Jan 31, 2017 | $146.62B | -0.3% |
| 2016 | Dec 30, 2016 | $147.07B | – |
See a number that looks wrong?